Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2025	Dec. 31, 2024
Current Assets
Cash and cash equivalents	$ 45,289	$ 37,139
Accounts receivable (net of allowance for credit losses of $1,802 and $2,630 at December 31, 2025 and 2024, respectively)	124,442	109,716
Contract assets	249,845	200,584
Inventories	182,788	196,881
Production cost of contracts	7,178	6,802
Other current assets	16,435	16,959
Total Current Assets	625,977	568,081
Property and Equipment, Net	107,223	109,812
Operating Lease Right-of-Use Assets	40,077	28,611
Goodwill	244,600	244,600
Intangibles, Net	132,839	149,591
Deferred Income Taxes	15,317	2,239
Other Assets	20,192	23,167
Total Assets	1,186,225	1,126,101
Current Liabilities
Accounts payable	74,653	75,784
Contract liabilities	40,694	34,445
Accrued and other liabilities	50,934	44,214
Operating lease liabilities	7,817	8,531
Current portion of long-term debt	5,000	12,500
Total Current Liabilities	179,098	175,474
Long-Term Debt, Less Current Portion	298,790	229,830
Non-Current Operating Lease Liabilities	34,223	21,284
Other Long-Term Liabilities	12,004	16,983
Total Liabilities	524,115	443,571
Commitments and Contingencies (Notes 13, 15)
Shareholders’ Equity
Common stock - $0.01 par value; 35,000,000 shares authorized; 14,949,671 and 14,781,218 shares issued and outstanding at December 31, 2025 and 2024, respectively	149	148
Additional paid-in capital	235,878	217,523
Retained earnings	419,537	453,475
Accumulated other comprehensive income	6,546	11,384
Total Shareholders’ Equity	662,110	682,530
Total Liabilities and Shareholders’ Equity	$ 1,186,225	$ 1,126,101